A Double-Blind, Crossover, Randomized Comparison of Granisetron and Ramosetron for the Prevention of Acute and Delayed Cisplatin-Induced Emesis in Patients with Gastrointestinal Cancer: Is Patient Preference a Better Primary Endpoint?

Publisher: Karger

E-ISSN: 1421-9794|49|6|316-323

ISSN: 0009-3157

Source: Chemotherapy, Vol.49, Iss.6, 2003-12, pp. : 316-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content